QT
Quanterix Corporation
QTRX · NASDAQ
$2.73 +1.49% (+$0.04)
1M +12.81%
Market Cap $128.6M
P/E Ratio -
Div. Yield -
ROE 43.59%
Bulios Fair Price
$1.88
31.1% downside
Current Price
$2.73
Undervalued Fair Value Overvalued
According to Bulios Fair Price, QTRX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.54x
P/S 0.84x
PEG N/A
Growth
51 /100
Stable Book val. growth 6.16%
Rev. growth 9.53%
FCF growth N/A
Profitability
17 /100
Weak FCF margin 48.25%
Op. margin 86.19%
Gross margin 42.60%
Quality
6 /100
Poor Asset turnover 0.48x
ROA 38.52%
ROIC 46.86%
Debt
100 /100
Low Current ratio 3.40x
Debt/Equity 0.14x
Net debt/EBITDA N/A
Stability
52 /100
Moderate Profitable years 0
EPS volatility 110.03%
Beta 1.04x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about QTRX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Everett V. Cunningham
Employees
450
Headquarters
Billerica
Upcoming events
09 NOV
Earnings
Upcoming earnings report